{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:36:37Z","timestamp":1787416597614,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients. The purpose of this study was to evaluate the effect of treatment with Irbesartan in type 2 diabetic patients with microalbuminuria on the urinary proteome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>High-resolution capillary-electrophoresis coupled to mass-spectrometry (CE-MS) was used to profile the low-molecular-weight proteome in urine of a subgroup of patients from a two year randomized irbesartan versus placebo therapy trial, which included hypertensive type 2 diabetic patients with microalbuminuria on ongoing antihypertensive medication (IRMA2-substudy).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We demonstrate that the therapy with 300 mg Irbesartan daily over a period of two years results in significant changes of the urinary proteome. Both, a classifier developed previously that consists of urinary peptides indicative of chronic kidney disease, as well as several individual peptides changed significantly after treatment. These changes were not observed in the placebo-treated individuals. Most prominent are changes of urinary collagen fragments associated with progression of diabetic nephropathy, indicating normalization in urinary peptides.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>CE-MS analysis of urine enabled identification of peptides as potential surrogate markers for renoprotection in microalbuminuric type 2 diabetic patients, which show persistent improvement after longterm treatment with Irbesartan. The results suggest that a major benefit of treatment by Irbesartan may be improvement of collagen turnover, reduction of fibrosis. They further suggest that urinary proteome analysis could be utilized to assess potential benefit of therapeutic intervention, providing statistically significant results even on a small population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-11-29","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T07:36:56Z","timestamp":1288683416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria"],"prefix":"10.1186","volume":"11","author":[{"given":"Sten","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Z\u00fcrbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Henrik","family":"Parving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,1]]},"reference":[{"key":"180_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337\/diacare.27.5.1047.","journal-title":"Diabetes Care"},{"key":"180_CR2","first-page":"1777","volume-title":"Brenner and Rector's the Kidney","author":"HH Parving","year":"2004","unstructured":"Parving HH, Mauer M, Ritz E: Diabetic nephropathy. Brenner and Rector's the Kidney. Edited by: Brenner BM. 2004, Philadelphia: WB Saunders, 1777-1818."},{"key":"180_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1056\/NEJM198402093100605","volume":"310","author":"CE Mogensen","year":"1984","unstructured":"Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984, 310: 356-360. 10.1056\/NEJM198402093100605.","journal-title":"N Engl J Med"},{"key":"180_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"D de Zeeuw","year":"2004","unstructured":"de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al: Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004, 110: 921-927. 10.1161\/01.CIR.0000139860.33974.28.","journal-title":"Circulation"},{"key":"180_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-H: Effects of Losartan on Renal and Cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001, 345: 861-869. 10.1056\/NEJMoa011161.","journal-title":"N Engl J Med"},{"key":"180_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1056\/NEJMoa011489","volume":"345","author":"HH Parving","year":"2001","unstructured":"Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001, 345: 870-878. 10.1056\/NEJMoa011489.","journal-title":"N Engl J Med"},{"key":"180_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001, 345: 851-860. 10.1056\/NEJMoa011303.","journal-title":"N Engl J Med"},{"key":"180_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2337\/diacare.25.4.742","volume":"25","author":"American Diabetes Association","year":"2002","unstructured":"American Diabetes Association: Diabetic Nephropathy. Diabetes Care. 2002, 25: 85-89. 10.2337\/diacare.25.2007.S85.","journal-title":"Diabetes Care"},{"key":"180_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1042\/CS20040103","volume":"107","author":"H Mischak","year":"2004","unstructured":"Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, et al: Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond). 2004, 107: 485-495. 10.1042\/CS20040103.","journal-title":"Clin Sci (Lond)"},{"key":"180_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jdiacomp.2004.10.002","volume":"19","author":"M Meier","year":"2005","unstructured":"Meier M, Kaiser T, Herrmann A, Knueppel S, Hillmann M, Koester P, et al: Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J Diabetes Complications. 2005, 19: 223-232. 10.1016\/j.jdiacomp.2004.10.002.","journal-title":"J Diabetes Complications"},{"key":"180_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1523-1755.2005.00394.x","volume":"68","author":"K Rossing","year":"2005","unstructured":"Rossing K, Mischak H, Parving HH, Christensen PK, Walden M, Hillmann M, et al: Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int. 2005, 68: 193-205. 10.1111\/j.1523-1755.2005.00394.x.","journal-title":"Kidney Int"},{"key":"180_CR12","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1681\/ASN.2006090956","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami M, et al: Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 2007, 18: 1057-1071. 10.1681\/ASN.2006090956.","journal-title":"J Am Soc Nephrol"},{"key":"180_CR13","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1002\/elps.200700237","volume":"28","author":"BA Julian","year":"2007","unstructured":"Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, et al: Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis. 2007, 28: 4469-4483. 10.1002\/elps.200700237.","journal-title":"Electrophoresis"},{"key":"180_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ki.2009.93","volume":"76","author":"AD Kistler","year":"2009","unstructured":"Kistler AD, Mischak H, Poster D, Dakna M, Wuthrich RP, Serra AL: Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2009, 76: 89-96. 10.1038\/ki.2009.93.","journal-title":"Kidney Int"},{"key":"180_CR15","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/ndt\/gfp063","volume":"24","author":"J Drube","year":"2009","unstructured":"Drube J, Schiffer E, Mischak H, Kemper MJ, Neuhaus T, Pape L, et al: Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant. 2009, 24: 2161-2169. 10.1093\/ndt\/gfp063.","journal-title":"Nephrol Dial Transplant"},{"key":"180_CR16","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1681\/ASN.2006050486","volume":"17","author":"G Candiano","year":"2006","unstructured":"Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del BP, et al: Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol. 2006, 17: 3139-3148. 10.1681\/ASN.2006050486.","journal-title":"J Am Soc Nephrol"},{"key":"180_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000086476","volume":"25","author":"MT Nguyen","year":"2005","unstructured":"Nguyen MT, Ross GF, Dent CL, Devarajan P: Early prediction of acute renal injury using urinary proteomics. Am J Nephrol. 2005, 25: 318-326. 10.1159\/000086476.","journal-title":"Am J Nephrol"},{"key":"180_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1373\/clinchem.2007.088260","volume":"53","author":"H Dihazi","year":"2007","unstructured":"Dihazi H, Muller GA, Lindner S, Meyer M, Asif AR, Oellerich M, et al: Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem. 2007, 53: 1636-1645. 10.1373\/clinchem.2007.088260.","journal-title":"Clin Chem"},{"key":"180_CR19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1681\/ASN.2007091025","volume":"19","author":"K Rossing","year":"2008","unstructured":"Rossing K, Mischak H, Dakna M, Z\u00fcrbig P, Novak J, Julian BA, et al: Urinary proteomics in diabetes and CKD. J Am Soc Nephrol. 2008, 19: 1283-1290. 10.1681\/ASN.2007091025.","journal-title":"J Am Soc Nephrol"},{"key":"180_CR20","volume-title":"Mol Cell Proteomics","author":"DM Good","year":"2010","unstructured":"Good DM, Zurbig P, Argiles A, Bauer HW, Behrens G, Coon JJ, et al: Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics. 2010,"},{"key":"180_CR21","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1074\/mcp.M800529-MCP200","volume":"8","author":"M Haubitz","year":"2009","unstructured":"Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, et al: Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in ANCA associated Vasculitis. Mol Cell Proteomics. 2009, 8: 2296-2307. 10.1074\/mcp.M800529-MCP200.","journal-title":"Mol Cell Proteomics"},{"key":"180_CR22","volume-title":"PLoS ONE","author":"A Alkhalaf","year":"2010","unstructured":"Alkhalaf A, Zuerbig P, Bakker SJL, Bilo HJ, Cerna M, Fischer C, et al: Multicentric validation of pproteomic biomarkers in urine specific for diabetic nephropathy. PLoS ONE. 2010,"},{"key":"180_CR23","volume-title":"Nephrol Dial Transplant","author":"H Mischak","year":"2010","unstructured":"Mischak H, Rossing P: Proteomic Biomarkers in diabetic nephropathy - reality or future promise?. Nephrol Dial Transplant. 2010,"},{"key":"180_CR24","volume-title":"Nephrol Dial Transplant","author":"RB Ameur","year":"2010","unstructured":"Ameur RB, Molina L, Bolvin C, Kifagi C, Jarraya F, Ayadi H, et al: Proteomic approaches for discovering biomarkers of diabetic nephropathy. Nephrol Dial Transplant. 2010,"},{"key":"180_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/CS20050085","volume":"109","author":"BC Vidal","year":"2005","unstructured":"Vidal BC, Bonventre JV, Hong HS: Towards the application of proteomics in renal disease diagnosis. Clin Sci (Lond). 2005, 109: 421-430. 10.1042\/CS20050085.","journal-title":"Clin Sci (Lond)"},{"key":"180_CR26","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1074\/mcp.R800001-MCP200","volume":"7","author":"S Decramer","year":"2008","unstructured":"Decramer S, Gonzalez de PA, Breuil B, Mischak H, Monsarrat B, Bascands JL, et al: Urine in clinical proteomics. Mol Cell Proteomics. 2008, 7: 1850-1862. 10.1074\/mcp.R800001-MCP200.","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"180_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/ndt\/gfq033","volume":"25","author":"F Molina","year":"2010","unstructured":"Molina F, Dehmer M, Perco P, Graber A, Girolami M, Spasovski G, et al: Systems biology: opening new avenues in clinical research. Nephrol Dial Transplant. 2010, 25 (4): 1015-8. 10.1093\/ndt\/gfq033.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"180_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/ndt\/gfq025","volume":"25","author":"AF Dominiczak","year":"2010","unstructured":"Dominiczak AF, Herget-Rosenthal S, Delles C, Fliser D, Fournier I, Graber A, et al: Systems biology to battle vascular disease. Nephrol Dial Transplant. 2010, 25 (4): 1019-22. 10.1093\/ndt\/gfq025.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"180_CR29","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/sj.ki.5001874","volume":"70","author":"H Zhou","year":"2006","unstructured":"Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, et al: Exosomal Fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006, 70 (10): 1847-57. 10.1038\/sj.ki.5001874.","journal-title":"Kidney Int"},{"key":"180_CR30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/pmic.200300661","volume":"4","author":"R Pieper","year":"2004","unstructured":"Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, et al: Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics. 2004, 4: 1159-1174. 10.1002\/pmic.200300661.","journal-title":"Proteomics"},{"key":"180_CR31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1523-1755.2002.kid565.x","volume":"62","author":"V Thongboonkerd","year":"2002","unstructured":"Thongboonkerd V, McLeish KR, Arthur JM, Klein JB: Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002, 62: 1461-1469. 10.1111\/j.1523-1755.2002.kid565.x.","journal-title":"Kidney Int"},{"key":"180_CR32","doi-asserted-by":"publisher","first-page":"13368","DOI":"10.1073\/pnas.0403453101","volume":"101","author":"T Pisitkun","year":"2004","unstructured":"Pisitkun T, Shen RF, Knepper MA: Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004, 101: 13368-13373. 10.1073\/pnas.0403453101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"180_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/elps.1150170716","volume":"17","author":"T Marshall","year":"1996","unstructured":"Marshall T, Williams K: Two-dimensional electrophoresis of human urinary proteins following concentration by dye precipitation. Electrophoresis. 1996, 17: 1265-1272. 10.1002\/elps.1150170716.","journal-title":"Electrophoresis"},{"key":"180_CR34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/clinchem\/37.5.621","volume":"37","author":"ZK Shihabi","year":"1991","unstructured":"Shihabi ZK, Konen JC, O'Connor ML: Albuminuria vs urinary total protein for detecting chronic renal disorders. Clin Chem. 1991, 37: 621-624.","journal-title":"Clin Chem"},{"key":"180_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0140-6736(88)92657-8","volume":"2","author":"JS Yudkin","year":"1988","unstructured":"Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988, 2: 530-533. 10.1016\/S0140-6736(88)92657-8.","journal-title":"Lancet"},{"key":"180_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/01.ASN.0000101031.52826.BE","volume":"15","author":"S Schaub","year":"2004","unstructured":"Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, et al: Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol. 2004, 15: 219-227. 10.1097\/01.ASN.0000101031.52826.BE.","journal-title":"J Am Soc Nephrol"},{"key":"180_CR37","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/mas.20051","volume":"24","author":"W Kolch","year":"2005","unstructured":"Kolch W, Neususs C, Pelzing M, Mischak H: Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev. 2005, 24: 959-977. 10.1002\/mas.20051.","journal-title":"Mass Spectrom Rev"},{"key":"180_CR38","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1021\/pr070529w","volume":"6","author":"DM Good","year":"2007","unstructured":"Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, et al: Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res. 2007, 6: 4549-4555. 10.1021\/pr070529w.","journal-title":"J Proteome Res"},{"key":"180_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1523-1755.2004.00352.x","volume":"65","author":"S Schaub","year":"2004","unstructured":"Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P: Urine protein profiling with surface-enhanced laser-desorption\/ionization time-of-flight mass spectrometry. Kidney Int. 2004, 65: 323-332. 10.1111\/j.1523-1755.2004.00352.x.","journal-title":"Kidney Int"},{"key":"180_CR40","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/prca.200900189","volume":"4","author":"H Mischak","year":"2010","unstructured":"Mischak H, Kolch W, Aivalotis M, Bouyssie D, Court M, Dihazi H, et al: Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl. 2010, 4: 464-478. 10.1002\/prca.200900189.","journal-title":"Proteomics Clin Appl"},{"key":"180_CR41","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1111\/j.1523-1755.2005.00335.x","volume":"67","author":"M Haubitz","year":"2005","unstructured":"Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, et al: Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005, 67: 2313-2320. 10.1111\/j.1523-1755.2005.00335.x.","journal-title":"Kidney Int"},{"key":"180_CR42","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/j.1523-1755.2004.00659.x","volume":"65","author":"EM Weissinger","year":"2004","unstructured":"Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, et al: Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 2004, 65: 2426-2434. 10.1111\/j.1523-1755.2004.00659.x.","journal-title":"Kidney Int"},{"key":"180_CR43","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1002\/elps.200400208","volume":"26","author":"D Theodorescu","year":"2005","unstructured":"Theodorescu D, Fliser D, Wittke S, Mischak H, Krebs R, Walden M, et al: Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis. 2005, 26: 2797-2808. 10.1002\/elps.200400208.","journal-title":"Electrophoresis"},{"key":"180_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2008.0040","volume":"11","author":"JK Snell-Bergeon","year":"2009","unstructured":"Snell-Bergeon JK, Maahs DM, Ogden LG, Kinney GL, Hokanson JE, Schiffer E, et al: Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. Diabetes Technol Ther. 2009, 11: 1-9. 10.1089\/dia.2008.0040.","journal-title":"Diabetes Technol Ther"},{"key":"180_CR45","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.2337\/diacare.26.12.3296","volume":"26","author":"S Andersen","year":"2003","unstructured":"Andersen S, Brochner-Mortensen J, Parving HH: Kidney function during and after withdrawal of long-term irbesartan treatment in patients with type 2 diabetes and microalbuminuria. Diabetes Care. 2003, 26: 3296-3302. 10.2337\/diacare.26.12.3296.","journal-title":"Diabetes Care"},{"key":"180_CR46","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/elps.200500827","volume":"27","author":"P Z\u00fcrbig","year":"2006","unstructured":"Z\u00fcrbig P, Renfrow MB, Schiffer E, Novak J, Walden M, Wittke S, et al: Biomarker discovery by CE-MS enables sequence analysis via MS\/MS with platform-independent separation. Electrophoresis. 2006, 27: 2111-2125. 10.1002\/elps.200500827.","journal-title":"Electrophoresis"},{"key":"180_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1470-2045(06)70584-8","volume":"7","author":"D Theodorescu","year":"2006","unstructured":"Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, et al: Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 2006, 7: 230-240. 10.1016\/S1470-2045(06)70584-8.","journal-title":"Lancet Oncol"},{"key":"180_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/rcm.1294","volume":"18","author":"N Neuhoff","year":"2004","unstructured":"Neuhoff N, Kaiser T, Wittke S, Krebs R, Pitt A, Burchard A, et al: Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption\/ionization and capillary electrophoresis\/mass spectrometry. Rapid Communications in Mass Spectrometry. 2004, 18: 149-156. 10.1002\/rcm.1294.","journal-title":"Rapid Communications in Mass Spectrometry"},{"key":"180_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/pr800401m","volume":"8","author":"J Jantos-Siwy","year":"2009","unstructured":"Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, et al: Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease. J Proteome Res. 2009, 8: 268-281. 10.1021\/pr800401m.","journal-title":"J Proteome Res"},{"key":"180_CR50","first-page":"318","volume-title":"DeLeo, J.M. Receiver operating characteristic laboratory (ROCLAB): Software for developing decision strategies that account for uncertainty","author":"JM DeLeo","year":"1993","unstructured":"DeLeo JM: DeLeo, J.M. Receiver operating characteristic laboratory (ROCLAB): Software for developing decision strategies that account for uncertainty. 1993, College Park, MD, USA, 318-325."},{"key":"180_CR51","first-page":"125","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B (Methodological). 1995, 57: 125-133.","journal-title":"J Royal Stat Soc B (Methodological)"},{"key":"180_CR52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/prca.200800024","volume":"2","author":"JJ Coon","year":"2008","unstructured":"Coon JJ, Z\u00fcrbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, et al: CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl. 2008, 2: 964-973. 10.1002\/prca.200800024.","journal-title":"Proteomics Clin Appl"},{"key":"180_CR53","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/prca.200780166","volume":"2","author":"K Rossing","year":"2008","unstructured":"Rossing K, Mischak H, Rossing P, Schanstra JP, Wiseman A, Maahs DM: The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy. Proteomics Clin Appl. 2008, 2: 997-1007. 10.1002\/prca.200780166.","journal-title":"Proteomics Clin Appl"},{"key":"180_CR54","doi-asserted-by":"publisher","first-page":"46ps42","DOI":"10.1126\/scitranslmed.3001249","volume":"2","author":"H Mischak","year":"2010","unstructured":"Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, et al: Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med. 2010, 2: 46ps42-","journal-title":"Sci Transl Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-11-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-11-29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-11-29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-11-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:58:42Z","timestamp":1630472322000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-11-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-11-29","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,1]]},"assertion":[{"value":"1 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}